Skip to content

ADAR1 Capital Management, LLC Insider Trading -- Recent SEC Form 4 Transactions

ADAR1 Capital Management, LLC (CIK 1940272) reported 53 SEC Form 4 insider transactions across 5 companies over the past 18 months (most recent 2026-10-08). Recent activity: Buy INM (5,601 shares), Buy INM (3,046 shares), Buy INM (2,256 shares), Buy INM (16,431 shares), Buy INM (8,307 shares). Source: SEC Form 4.

DateCompanyRoleTypeSharesValue
2026-10-08InMed Pharmaceuticals Inc. (INM)10% OwnerBuy5,601$7,436
2026-10-08InMed Pharmaceuticals Inc. (INM)10% OwnerBuy3,046$4,051
2026-10-08InMed Pharmaceuticals Inc. (INM)10% OwnerBuy2,256$2,997
2026-10-05InMed Pharmaceuticals Inc. (INM)10% OwnerBuy16,431$21,850
2026-10-05InMed Pharmaceuticals Inc. (INM)10% OwnerBuy8,307$11,048
2026-10-05InMed Pharmaceuticals Inc. (INM)10% OwnerBuy18,182$24,182
2026-09-16InMed Pharmaceuticals Inc. (INM)10% OwnerBuy28,505$36,880
2026-09-16InMed Pharmaceuticals Inc. (INM)10% OwnerBuy54,256$70,446
2026-09-16InMed Pharmaceuticals Inc. (INM)10% OwnerBuy8,340$10,750
2026-09-08TENAX THERAPEUTICS, INC. (TENX)10% OwnerBuy900,000$1.6M
2026-09-02TENAX THERAPEUTICS, INC. (TENX)10% OwnerBuy187,704$337,586
2026-09-02TENAX THERAPEUTICS, INC. (TENX)10% OwnerBuy179,058$321,570
2026-09-02TENAX THERAPEUTICS, INC. (TENX)10% OwnerBuy403,571$722,594
2026-08-24TENAX THERAPEUTICS, INC. (TENX)10% OwnerBuy202,124$359,538
2026-08-24TENAX THERAPEUTICS, INC. (TENX)10% OwnerBuy716,369$1.3M
2026-08-24TENAX THERAPEUTICS, INC. (TENX)10% OwnerBuy107,374$188,355
2026-08-03NextCure, Inc. (NXTC)10% OwnerBuy50,000$248,615
2026-08-03NextCure, Inc. (NXTC)10% OwnerBuy20,000$100,000
2026-08-03NextCure, Inc. (NXTC)10% OwnerBuy20,000$100,000
2026-08-03NextCure, Inc. (NXTC)10% OwnerBuy25,000$120,338
2026-08-03NextCure, Inc. (NXTC)10% OwnerBuy100,000$490,000
2026-08-03NextCure, Inc. (NXTC)10% OwnerBuy77,850$385,793
2026-08-03NextCure, Inc. (NXTC)10% OwnerBuy3,300$16,420
2026-08-03NextCure, Inc. (NXTC)10% OwnerBuy25,000$124,540
2026-08-03NextCure, Inc. (NXTC)10% OwnerBuy8,003$38,414

Source: SEC Form 4 filings · as of 2026-10-08